Senseonics Holdings Inc. (SENS) experienced a 9.2% pre-market plunge on Tuesday, following the release of its fourth quarter and full-year 2024 financial results. While the medical technology company reported a modest increase in revenue, its widening net losses appeared to disappoint investors.

For the full year 2024, Senseonics reported a net loss of $78.6 million, or $0.12 per share, a significant increase from the net loss of $60.4 million, or $0.11 per share, in 2023. The company cited a reduction in gains due to the exchange of outstanding convertible notes and changes in the fair value of derivatives as contributing factors to the widening losses.

Despite the revenue growth, with Q4 revenue reaching $8.3 million and full-year revenue of $22.5 million, the company's mounting losses appear to have overshadowed the positive news, leading to a sell-off in the pre-market trading session.